RI
ATRA icon

RTW Investments’s Atara Biotherapeutics ATRA Stock Holding History

RTW Investments’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-22,245
Closed -$10.1M – 39
2017
Q4 		$10.1M Sell
22,245
-3,996
-15% -$1.48M 1.68% 19
2017
Q3 		$10.9M Sell
26,241
-20,669
-44% -$7.79M 1.89% 18
2017
Q2 		$16.4M Buy
46,910
+10,561
+29% +$4.07M 3.46% 10
2017
Q1 		$18.7M Buy
36,349
+21,444
+144% +$8.88M 4.92% 8
2016
Q4 		$5.29M Sell
14,905
-3,420
-19% -$1.45M 1.99% 15
2016
Q3 		$9.8M Sell
18,325
-310
-2% -$168K 2.96% 11
2016
Q2 		$10.5M Sell
18,635
-290
-2% -$139K 3.58% 11
2016
Q1 		$9M Buy
18,925
+1,568
+9% +$706K 3.27% 14
2015
Q4 		$11.5M Buy
17,357
+6,837
+65% +$5.17M 3.73% 9
2015
Q3 		$8.27M Buy
+10,520
New +$12.8M 2.57% 13

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return